Farooqui T - Search Results

1

Synthesis and D2 dopaminergic activity of pyrrolidinium, tetrahydrothiophenium, and tetrahydrothiophene analogues of sulpiride.

Harrold MW, Wallace RA, Farooqui T, Wallace LJ, Uretsky N, Miller DD. Harrold MW, et al. Among authors: farooqui t. J Med Chem. 1989 Apr;32(4):874-80. doi: 10.1021/jm00124a024. J Med Chem. 1989. PMID: 2522993

2

Effect of the inhibition of dopamine uptake on the dopamine- and dimethyldopamine-induced-inhibition of the potassium-evoked release of [3H]acetylcholine from striatal slices.

Farooqui T, Wallace RA, Miller DD, Uretsky NJ. Farooqui T, et al. Gen Pharmacol. 1989;20(6):731-6. doi: 10.1016/0306-3623(89)90320-0. Gen Pharmacol. 1989. PMID: 2591702

3

Charged analogues of chlorpromazine as dopamine antagonists.

Harrold MW, Chang YA, Wallace RA, Farooqui T, Wallace LJ, Uretsky N, Miller DD. Harrold MW, et al. Among authors: farooqui t. J Med Chem. 1987 Sep;30(9):1631-5. doi: 10.1021/jm00392a019. J Med Chem. 1987. PMID: 2887659

4

Interaction of permanently charged analogs of dopamine with the D-2 dopaminergic receptor.

Wallace RA, Farooqui T, Wallace L, Ares J, Chang YA, Miller D, Uretsky N. Wallace RA, et al. Among authors: farooqui t. Biochem Pharmacol. 1987 Nov 15;36(22):3903-10. doi: 10.1016/0006-2952(87)90456-4. Biochem Pharmacol. 1987. PMID: 2961340

5

Interaction of permanently uncharged dopamine analogs with the D-2 dopaminergic receptor.

Wallace RA, Farooqui T, Wallace L, Ares J, Chang YA, Miller D, Uretsky N. Wallace RA, et al. Among authors: farooqui t. Biochem Pharmacol. 1988 May 15;37(10):2077-84. doi: 10.1016/0006-2952(88)90559-x. Biochem Pharmacol. 1988. PMID: 2967702

6

Effect of permanently charged and uncharged dopaminergic agonists on the potassium-induced release of [3H]acetylcholine from striatal slices.

Sabol B, Boldry R, Farooqui T, Chang YA, Miller D, Uretsky N. Sabol B, et al. Among authors: farooqui t. Biochem Pharmacol. 1987 May 15;36(10):1679-85. doi: 10.1016/0006-2952(87)90054-2. Biochem Pharmacol. 1987. PMID: 3109428

7

Dopamine agonists: effects of charged and uncharged analogues of dopamine.

Chang YA, Ares J, Anderson K, Sabol B, Wallace RA, Farooqui T, Uretsky N, Miller DD. Chang YA, et al. Among authors: farooqui t. J Med Chem. 1987 Jan;30(1):214-8. doi: 10.1021/jm00384a038. J Med Chem. 1987. PMID: 3806598

8

Interaction of permanently charged metoclopramide analogs with D-2 dopamine receptors.

Farooqui T, Brooks K, Harrold MW, Miller DD, Wallace LJ, Uretsky NJ. Farooqui T, et al. Gen Pharmacol. 1994 Dec;25(8):1577-84. doi: 10.1016/0306-3623(94)90357-3. Gen Pharmacol. 1994. PMID: 7721031

9

The interaction of ammonium, sulfonium, and sulfide analogues of metoclopramide with the dopamine D2 receptor.

Harrold MW, Sriburi A, Matsumoto K, Miller DD, Farooqui T, Uretsky N. Harrold MW, et al. Among authors: farooqui t. J Med Chem. 1993 Oct 15;36(21):3166-70. doi: 10.1021/jm00073a017. J Med Chem. 1993. PMID: 8230103

10

Interaction of AZA analogs of chlorpromazine with the dopamine D2 receptor.

Farooqui T, Markovich K, Wallace L, Miller D, Uretsky N. Farooqui T, et al. Gen Pharmacol. 1993 Jan;24(1):147-51. doi: 10.1016/0306-3623(93)90026-t. Gen Pharmacol. 1993. PMID: 8482489

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters